Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
Hanenberg H, Roellecke K, Wiek C. Hanenberg H, et al. Among authors: roellecke k. Curr Gene Ther. 2017;16(5):309-320. doi: 10.2174/1566523217666170109111958. Curr Gene Ther. 2017. PMID: 28067166 Review.
Optimized NGFR-derived hinges for rapid and efficient enrichment and detection of CAR T cells in vitro and in vivo.
Bister A, Ibach T, Haist C, Gerhorst G, Smorra D, Soldierer M, Roellecke K, Wagenmann M, Scheckenbach K, Gattermann N, Wiek C, Hanenberg H. Bister A, et al. Among authors: roellecke k. Mol Ther Oncolytics. 2022 Jun 6;26:120-134. doi: 10.1016/j.omto.2022.05.012. eCollection 2022 Sep 15. Mol Ther Oncolytics. 2022. PMID: 35795096 Free PMC article.
Influence of Stereochemistry on the Bioactivation and Glucuronidation of 4-Ipomeanol.
Teitelbaum AM, McDonald MG, Kowalski JP, Parkinson OT, Scian M, Whittington D, Roellecke K, Hanenberg H, Wiek C, Rettie AE. Teitelbaum AM, et al. Among authors: roellecke k. J Pharmacol Exp Ther. 2019 Feb;368(2):308-316. doi: 10.1124/jpet.118.249771. Epub 2018 Nov 8. J Pharmacol Exp Ther. 2019. PMID: 30409834 Free PMC article.
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G.
Kailayangiri S, Altvater B, Spurny C, Jamitzky S, Schelhaas S, Jacobs AH, Wiek C, Roellecke K, Hanenberg H, Hartmann W, Wiendl H, Pankratz S, Meltzer J, Farwick N, Greune L, Fluegge M, Rossig C. Kailayangiri S, et al. Among authors: roellecke k. Oncoimmunology. 2016 Oct 28;6(1):e1250050. doi: 10.1080/2162402X.2016.1250050. eCollection 2017. Oncoimmunology. 2016. PMID: 28197367 Free PMC article.